Market Overview

Jefferies Downgrades Metabolix to Hold

Jefferies & Company has downgraded Metabolix (NASDAQ: MBLX) from Buy to Hold and has lowered the price target from $9 to $4.

Posted-In: Jefferies & CompanyDowngrades Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (MBLX)

Around the Web, We're Loving...

Get Benzinga's Newsletters